341 related articles for article (PubMed ID: 25262921)
1. Minor histocompatibility antigens: past, present, and future.
Spierings E
Tissue Antigens; 2014 Oct; 84(4):374-60. PubMed ID: 25262921
[TBL] [Abstract][Full Text] [Related]
2. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
3. Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation.
Spierings E; Goulmy E
Methods Mol Biol; 2012; 882():509-30. PubMed ID: 22665253
[TBL] [Abstract][Full Text] [Related]
4. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
[TBL] [Abstract][Full Text] [Related]
5. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
6. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions.
Akatsuka Y; Morishima Y; Kuzushima K; Kodera Y; Takahashi T
Cancer Sci; 2007 Aug; 98(8):1139-46. PubMed ID: 17521316
[TBL] [Abstract][Full Text] [Related]
7. Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.
Stevanović S; Nijmeijer BA; van Schie ML; Salvatori DC; Maas S; Griffioen M; Falkenburg JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):867-75. PubMed ID: 23500532
[TBL] [Abstract][Full Text] [Related]
8. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
9. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
10. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
Spierings E
Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
[TBL] [Abstract][Full Text] [Related]
11. Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Turpeinen H; Ojala PJ; Ojala K; Miettinen M; Volin L; Partanen J
Int J Immunogenet; 2013 Dec; 40(6):495-501. PubMed ID: 23480177
[TBL] [Abstract][Full Text] [Related]
12. The expanding horizon of immunotherapy in the treatment of malignant disorders: allogeneic hematopoietic stem cell transplantation and beyond.
Tsirigotis P; Shimoni A; Nagler A
Ann Med; 2014 Sep; 46(6):384-96. PubMed ID: 24888385
[TBL] [Abstract][Full Text] [Related]
13. The relevance of minor histocompatibility antigens in solid organ transplantation.
Dierselhuis M; Goulmy E
Curr Opin Organ Transplant; 2009 Aug; 14(4):419-25. PubMed ID: 19444105
[TBL] [Abstract][Full Text] [Related]
14. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.
Choi EY; Choi K; Nam G; Kim W; Chung M
Front Immunol; 2020; 11():1163. PubMed ID: 32587590
[TBL] [Abstract][Full Text] [Related]
15. Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.
Griffioen M; Honders MW; van der Meijden ED; van Luxemburg-Heijs SA; Lurvink EG; Kester MG; van Bergen CA; Falkenburg JH
Haematologica; 2012 Aug; 97(8):1196-204. PubMed ID: 22419570
[TBL] [Abstract][Full Text] [Related]
16. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract][Full Text] [Related]
17. [Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)].
Tanaka J
Nihon Rinsho; 2003 Sep; 61(9):1512-9. PubMed ID: 14515717
[TBL] [Abstract][Full Text] [Related]
18. Non-myeloablative transplants for malignant disease.
Storb RF; Champlin R; Riddell SR; Murata M; Bryant S; Warren EH
Hematology Am Soc Hematol Educ Program; 2001; ():375-91. PubMed ID: 11722994
[TBL] [Abstract][Full Text] [Related]
19. Targeting alloreactive donor T-cells to hematopoietic system-restricted minor histocompatibility antigens to dissect graft-versus-leukemia effects from graft-versus-host disease after allogeneic stem cell transplantation.
Mutis T
Int J Hematol; 2003 Oct; 78(3):208-12. PubMed ID: 14604278
[TBL] [Abstract][Full Text] [Related]
20. [Antigen-specific allogeneic immunotherapy--selective augmentation of GVL effects].
Akatsuka Y
Gan To Kagaku Ryoho; 2008 May; 35(5):713-9. PubMed ID: 18487905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
